Recompensation has gained increasing attention in the field of cirrhosis, particularly in
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …

There is a universal agreement that the occurrence of clinical complications, such as ascites,
hepatic encephalopathy, gastrointestinal bleeding, and jaundice mark the transition from the …

Viral Hepatitis - Infectious Disease Clinics Skip to Main Content Advertisement Infectious
Disease Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com theclinics.com …

Summary Direct-acting antiviral (DAA)-induced HCV clearance conceivably leads to
improved outcomes at all stages of liver disease. However, available data suggest that the …

Traditionally, the complications of cirrhosis, namely variceal bleeding, ascites and hepatic
encephalopathy, were thought to result predominantly from circulatory dysfunction and …

Traditionally, the progression from compensated to decompensated cirrhosis has been
regarded as a point of no return in the natural history of the disease. However, this point of …

The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver
Cancer (BCLC)-B/C hepatocellular carcinoma (HCC) is understudied. HCC patients have …

Background Direct-acting antiviral (DAA) therapy enables a high rate of sustained virologic
response (SVR) in patients with hepatitis C virus associated cirrhosis. However, the impact …

Background Real-world data on the efficacy and safety of sofosbuvir plus velpatasvir
(SOF/VEL) treatment for patients with hepatitis C virus (HCV)-related decompensated …

DAA therapy is known to clear hepatitis C virus infection in patients with decompensated
cirrhosis (DC). However, the safety and benefits of DAA in DC remain unclear, especially …